Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$230.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| — |
| — |
| Open the original filing on SEC.gov |
| Mar 12 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 3,750 | — | — | +76.6% | Open the original filing on SEC.gov |
| Mar 10 | XENE | Xenon Pharmaceuticals Inc. | SSELL◷ | 2,607 | $60.11 | $156.7K | -34.8% | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | XENE | Xenon Pharmaceuticals Inc. | MEXER◷ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Jan 9 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 9 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 80,000 | — | — | — | Open the original filing on SEC.gov |